Ress Life Investments A/S publishes Net Asset Value (NAV).

Ress Life Investments reported NAV per share of $2,748.58 as of 15 September 2026. Performance was -0.06% for the first half of September, while year-to-date net performance was +4.17%; assets under management totaled $227.6 million. The announcement is a routine NAV update with limited expected market impact.

Analysis

This is not a fundamental catalyst for NDAQ: the disclosed vehicle is a small listed fund, and its asset base is immaterial to Nasdaq’s revenue, trading volumes, or index/franchise economics. The relevant market implication is limited to the fund’s own secondary-market liquidity and any discount/premium to NAV, which cannot be assessed without the Copenhagen-listed share price, bid/ask depth, and redemption terms.

The modest year-to-date NAV progression provides no independently verifiable read-through on the underlying life-settlement portfolio’s valuation marks, mortality assumptions, or cash realization pace. In this asset class, reported NAV can remain stable while liquidity risk and model-risk accumulate; the more decision-useful catalysts are audited annual valuations, material changes in discount-rate or longevity assumptions, and actual redemption activity over the next 1-3 months.

No directional trade is warranted on NDAQ. For investors able to access the fund, monitor whether its market price diverges materially from reported NAV after accounting for FX conversion and dealing costs; a persistent discount could reflect illiquidity rather than mispricing, particularly if redemptions are gated or infrequent. A 6-18 month structural risk is that higher required returns for illiquid alternative assets force NAV-mark pressure, but the announcement alone does not establish that condition.

Key Decisions for Investors

• Take no action in NDAQ; this disclosure is immaterial relative to Nasdaq’s earnings base and contains no catalyst for estimates or valuation.
• Place a watch alert on Ress Life Investments’ Copenhagen trading price versus converted EUR NAV; investigate only if the discount exceeds 10-15% and subscription/redemption mechanics permit a credible convergence trade.
• Before considering any fund position, obtain dealing frequency, notice periods, gates, portfolio duration, audited valuation methodology, and sensitivity to mortality and discount-rate assumptions; absent these data, treat any NAV discount as a liquidity-risk signal rather than an arbitrage opportunity.
• Reassess after the next audited reporting period or any update showing redemptions, realized policy maturities, or changes to valuation assumptions; those events, rather than a routine NAV publication, would be the thesis-defining catalyst.